Recent evidence reported that cAMP/PKA enhances IL-1β induced-IL-6 synthesis through Jak2/Stat3 activation, identifying novel therapeutic targets for the treatment of glioma [41]. This evidence concerns the gene IL1B and central nervous system cancer.